niche

Paraquat Aerial Spray Drift

Preparing your case review…
Written By
People's Justice Legal Research Team

How Paraquat Spray Drift Exposes Rural Communities

When paraquat is applied by aircraft or ground rigs, a portion of the spray inevitably drifts beyond the target area. The distance and concentration of drift depend on multiple factors including wind speed and direction, droplet size, application height, temperature, humidity, and the specific application equipment used. Under certain conditions, paraquat drift can travel hundreds of meters to several kilometers from the application site, exposing anyone in the downwind area.

Aerial application produces the most extensive drift patterns due to the height from which the spray is released and the difficulty of controlling droplet placement from a moving aircraft. Crop dusting operations in the Midwest, Central Valley of California, and Southern agricultural regions applied millions of pounds of paraquat by air over decades. Rural residents living near these operations were exposed repeatedly during each growing season, accumulating significant cumulative doses over years and decades.

The populations most affected by drift exposure include rural homeowners living adjacent to treated fields, children attending rural schools near agricultural operations, outdoor workers in adjacent non-agricultural properties, and anyone who spent time outdoors in rural areas during or shortly after paraquat applications. These individuals were exposed to a restricted-use pesticide without their knowledge or consent.

Proving Drift Exposure in the Litigation

Drift exposure claims require demonstrating proximity to paraquat application sites and the occurrence of drift events. Evidence can include residential history showing proximity to agricultural land where paraquat was used, aerial application records from neighboring farms, USDA and state agriculture department records of paraquat purchases and applications in the area, testimony from neighbors and community members about crop dusting operations, and historical satellite imagery showing the proximity of homes and schools to treated fields.

Expert witnesses in the litigation use atmospheric dispersion modeling to reconstruct drift patterns based on historical weather data, application records, and geographic information. These models can estimate the concentration of paraquat that would have reached a plaintiff’s residence or school based on the known application sites and conditions.

Research & Evidence

Scientific Evidence

cross-sectional

Paraquat and Parkinson’s Disease: The Role of Corporate Agnotology

Dorsey ER, et al. (2023). Movement Disorders

Key Findings

  • Syngenta’s corporate predecessor ICI identified paraquat neurotoxicity in 1958 and confirmed brain penetration in 1966
  • The Louise Marks studies documenting substantia nigra cell loss in paraquat-exposed animals were suppressed and not reported to regulators
  • Syngenta’s 2003 "Scientific Influencing Strategy" was a coordinated effort to selectively publish favorable research while discrediting independent scientists
  • Syngenta specifically targeted Dr. Deborah Cory-Slechta and hired v-Fluence to manage reputation and influence scientific discourse
  • The pattern mirrors tobacco industry agnotology documented by Proctor and others, representing a deliberate corporate strategy to maintain a profitable product at the expense of public health
meta-analysis

Exposure to Pesticides or Solvents and Risk of Parkinson Disease (Meta-Analysis)

Pezzoli G, Cereda E. (2013). Neurology

Key Findings

  • Paraquat exposure was associated with an overall odds ratio of 1.64 for Parkinson’s disease, confirming a statistically significant increased risk
  • The association was consistent across multiple independent studies conducted in different countries and populations
  • Herbicide and pesticide exposure in general was associated with a pooled odds ratio of 1.62 for Parkinson’s disease
  • The meta-analytic approach provides the aggregated statistical power that individual studies cannot achieve, strengthening the causal inference
cohort

Rotenone, Paraquat, and Parkinson’s Disease (FAME Study)

Tanner CM, Kamel F, Ross GW, et al. (2011). Environmental Health Perspectives

Key Findings

  • Paraquat users had a 2.5-fold (250%) increased risk of Parkinson’s disease compared to non-users
  • The association was statistically significant and persisted after controlling for confounding variables including age, sex, smoking, and other pesticide exposures
  • Rotenone use was also associated with increased Parkinson’s risk (2.5x), and both compounds inhibit mitochondrial complex I through similar mechanisms
  • The study used objective pesticide application records rather than self-reported exposure, substantially reducing recall bias
FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Related Topics

Related Pages

Paraquat & Early-Onset Parkinson’s

Early-onset Parkinson’s disease (diagnosed before age 50) is more strongly associated with environmental exposures like paraquat than late-onset cases. Individuals who developed Parkinson’s at a younger age after paraquat exposure may have particularly strong claims because early onset is a marker of environmental causation rather than normal aging.

early-onsetyoung-onsetparkinsons
Learn more

Paraquat EPA Ban

Despite more than 70 countries banning paraquat and overwhelming scientific evidence linking it to Parkinson’s disease, the U.S. Environmental Protection Agency has repeatedly declined to ban the herbicide. The EPA’s 2024 registration review reaffirmed paraquat’s approval despite 90 studies submitted by the Michael J. Fox Foundation. This regulatory failure is cited in the litigation as evidence that judicial remedies are necessary to protect American farmworkers and rural communities.

epabanregulation
Learn more

Paraquat Farmworker Exposure

Agricultural workers and farmworkers bear the heaviest burden of paraquat exposure. An estimated 10 million pounds of paraquat are applied annually in the United States, and farmworkers — the majority of whom are Latino — face direct exposure through field work, crop handling, and inadequate protective equipment. The paraquat litigation seeks compensation for farmworkers who developed Parkinson’s disease as a result of occupational exposure.

farmworkeragricultural-workeroccupational-exposure
Learn more

Paraquat Parkinson’s Disease Lawsuit

Paraquat exposure causes Parkinson’s disease through a well-characterized mechanism of oxidative stress, mitochondrial dysfunction, and selective dopaminergic neuron death. The FAME study found a 2.5x increased risk, and MDL 3004 encompasses approximately 5,000 cases seeking compensation for individuals diagnosed with Parkinson’s after paraquat exposure.

parkinsonslawsuitparaquat
Learn more

Paraquat Settlement Amounts

Paraquat Parkinson’s settlement amounts are projected to range from $20,000 for early-stage cases to over $1,000,000 for severe, long-duration cases with strong exposure documentation. The MDL framework settlement agreement reached in April 2025 provides the structure for individual case resolution. Average projected settlements are $600,000 to $900,000. Filing now positions your claim for the current settlement distribution cycle.

settlementcompensationdamages
Learn more

Syngenta Paraquat Lawsuit

Syngenta is the primary defendant in the paraquat Parkinson’s litigation. The company, formed in 2000 from the merger of ICI/Zeneca and Novartis crop sciences, inherited decades of internal research documenting paraquat’s neurotoxicity. Syngenta implemented a "Scientific Influencing Strategy" to suppress and discredit this evidence. Acquired by ChemChina for $43 billion in 2017, Syngenta has paid $187.5 million in initial settlements and agreed to a broader framework settlement in April 2025.

syngentaicizeneca
Learn more

Paraquat Wrongful Death Claims

Surviving family members can file wrongful death claims on behalf of loved ones who died from Parkinson’s disease caused by paraquat exposure. Parkinson’s is a progressive and ultimately fatal disease, and many paraquat-exposed individuals have already passed away. Wrongful death claims seek compensation for medical costs before death, funeral expenses, lost financial support, and loss of companionship.

wrongful-deathsurvival-actionfamily-claims
Learn more
Parent Case

Paraquat Parkinson’s Lawsuit

Paraquat is a restricted-use herbicide manufactured primarily by Syngenta and distributed by Chevron Phillips Chemical and Growmark. Despite being banned in more than 70 countries including the European Union, China, Brazil, and Thailand, paraquat remains legal in the United States, where approximately 10 million pounds are applied annually. Scientific evidence — including the landmark Farming and Movement Evaluation (FAME) study published in 2011 — demonstrates that paraquat exposure increases the risk of Parkinson’s disease by 2.5 times. The mechanism is well understood: paraquat triggers oxidative stress through redox cycling, inhibits mitochondrial complex I, and selectively kills dopamine-producing neurons in the substantia nigra, leading to the progressive motor and cognitive deterioration characteristic of Parkinson’s disease. MDL 3004 was established in June 2021 in the Southern District of Illinois, with approximately 5,000 cases pending. Bellwether proceedings and settlement negotiations are ongoing, with projected individual settlements ranging from $20,000 to over $1,000,000 depending on disease severity and exposure documentation.

View full case overview